Key result
Surgical excision of rare left ventricular myxoma presenting with MI yields no recurrence at 18 months.
Why the study?
Left ventricular myxomas are extremely rare and can present with critical signs of ischemia or embolism, such as myocardial infarction without coronary artery disease.
Case Report (n=1)
No
Left ventricular myxomas are a rare but treatable cause of embolic myocardial infarction that can be successfully managed with prompt surgical excision.
Prompt surgical excision may yield favorable short-term outcomes in rare LV myxoma with embolic MI; leaves open generalizability from this single case.
Although myxoma represents the most frequent non-malignant cardiac primary tumor; it is extremely rare met in the left ventricle. Clinical features of the neoplasm extend from symptomless to critical signs of either ischemia or embolism. We describe here an unusual case of a huge left ventricular myxoma in a 68-year-old man, presented with clinical and ECG findings of an inferior wall myocardial infarction. The patient was primarily referred to our institution for coronary angiography, which showed no coronary artery disease. Further examinations revealed a left ventricular mass as the possible source of embolization, thus the patient underwent surgery for tumor excision. The postoperative course was unremarkable. A bibliographical analysis demonstrated that those tumors are rare but treatable causes of embolic myocardial infarction, thus profound clinical intuition, proper utilization of imaging modalities, administration of anticoagulants preoperatively, as well immediate surgical removal are justified.
No takes yet. Share an insight, caveat, or question.
Spiliopoulos et al. (2021) conducted a case report in Left ventricular myxoma presenting as acute myocardial infarction (n=1). Surgical excision was evaluated on Postoperative course and recurrence. Surgical excision of a rare left ventricular myxoma presenting as an embolic inferior wall myocardial infarction resulted in an unremarkable postoperative course with no recurrence at 18 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: